LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

Search

Insulet Corp

Închisă

SectorSănătate

315.14 -0.38

Rezumat

Modificarea prețului

24h

Curent

Minim

314.52

Maxim

322.66

Indicatori cheie

By Trading Economics

Venit

-65M

35M

Vânzări

-29M

569M

P/E

Medie Sector

56.955

56.602

EPS

1.02

Marjă de profit

6.221

Angajați

3,900

EBITDA

25M

142M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+2.02% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

2.6B

22B

Deschiderea anterioară

315.52

Închiderea anterioară

315.14

Sentimentul știrilor

By Acuity

19%

81%

39 / 382 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bearish Evidence

Insulet Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 mai 2025, 23:20 UTC

Câștiguri

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

13 mai 2025, 23:48 UTC

Market Talk

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

13 mai 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

13 mai 2025, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

13 mai 2025, 23:24 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

13 mai 2025, 23:24 UTC

Market Talk
Câștiguri

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

13 mai 2025, 22:58 UTC

Câștiguri

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mai 2025, 22:58 UTC

Câștiguri

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mai 2025, 22:58 UTC

Câștiguri

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

13 mai 2025, 22:58 UTC

Câștiguri

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

13 mai 2025, 22:38 UTC

Câștiguri

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

13 mai 2025, 22:38 UTC

Câștiguri

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

13 mai 2025, 22:37 UTC

Câștiguri

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

13 mai 2025, 22:36 UTC

Câștiguri

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

13 mai 2025, 22:35 UTC

Câștiguri

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

13 mai 2025, 22:34 UTC

Câștiguri

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

13 mai 2025, 22:33 UTC

Câștiguri

Aristocrat: Interactive Business Delivered Strong Revenue Growth

13 mai 2025, 22:33 UTC

Câștiguri

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

13 mai 2025, 22:33 UTC

Câștiguri

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

13 mai 2025, 22:30 UTC

Câștiguri

Aristocrat Interim Dividend 44 Australian Cents/Share

13 mai 2025, 22:30 UTC

Câștiguri

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

13 mai 2025, 22:29 UTC

Câștiguri

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

13 mai 2025, 22:28 UTC

Câștiguri

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

13 mai 2025, 21:15 UTC

Câștiguri

Nu Holdings 1Q Rev $3.2B >NU

13 mai 2025, 21:03 UTC

Top știri

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

13 mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

13 mai 2025, 20:32 UTC

Câștiguri

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 mai 2025, 20:31 UTC

Câștiguri

Alcon 1Q Sales $2.45B >ALC.EB

13 mai 2025, 20:30 UTC

Câștiguri

Alcon 1Q Rev $2.47B >ALC.EB

13 mai 2025, 20:30 UTC

Câștiguri

Alcon 1Q EPS 70c >ALC.EB

Comparație

Modificare preț

Insulet Corp Așteptări

Obiectiv de preț

By TipRanks

2.02% sus

Prognoză pe 12 luni

Medie 323.06 USD  2.02%

Maxim 360 USD

Minim 266 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruInsulet Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

18 ratings

15

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

252.29 / 259.38Suport & Rezistență

Termen scurt

Weak Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

39 / 382 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.